CYTOMARK LIMITED

Company number 11863469 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£107,753

Balance sheet as at 2025-12-31

View full accounts →

What it does

Manufacture of medical and dental instruments and supplies.

The company's own description, from its latest filed accounts.

Overview

Company type
Private Limited Company
Incorporated
2019-03-06
Employees
5 (2025 accounts · was 4 in 2024)
Registered office
Whiteleaf Business Centre 11 Little Balmer, Buckingham Industrial Estate, Buckingham, Buckinghamshire, United Kingdom, MK18 1TF
Postcode
MK18 1TF
Capital
102,219 GBP
Accounts category
Total Exemption Full

Accounts

Last made up to
2025-12-31
Next due by
2027-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2026-03-05
Next due by
2027-03-19
View filing history →

Nature of business (SIC)

  • 32500 Manufacture of medical and dental instruments and supplies

Officers 3 current

Appointed 2019-03-06
Dean COUPAR Director
Appointed 2019-03-06
James OTTER Director
Appointed 2019-03-06

View all officers and resignations →

Group structure

Controlled by CALTAG MEDSYSTEMS LIMITED — since 2025-08-14

From persons-with-significant-control filings on the public register.

Contact details

Website
cytomark.co.uk

TransFix Cell Stabilisation Reagent for Flow Cytometry. Preserves antigen expression for blood, Cerebrospinal (CSF) bone marrow, lymph nodes, and CTCs

Among its peers

Top 25%

by shareholders' funds, of 21 similar companies in MK

Trading since 2019.

181 companies are registered at this postcode →

Competitors Milton Keynes

This company ranks 4 among manufacture of medical and dental instruments and supplies in Milton Keynes.

Full league table →

The class of 2019

40%

of the 286 companies in this sector incorporated in 2019 are still active today; 54% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →